Charles Schwab Investment Management Inc Castle Biosciences Inc Transaction History

Charles Schwab Investment Management Inc

  • $429 Billion
  • Q1 2024

A detailed history of Charles Schwab Investment Management Inc transactions in Castle Biosciences Inc stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 204,937 shares of CSTL stock, worth $4.46 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
204,937
Previous 207,295 1.14%
Holding current value
$4.46 Million
Previous $4.47 Million 1.48%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 08, 2024
SELL
$18.06 - $25.3 $42,585 - $59,657
-2,358 Reduced 1.14%
204,937 $4.54 Million
Q4 2023

Feb 06, 2024
BUY
$12.19 - $22.43 $76,870 - $141,443
6,306 Added 3.14%
207,295 $4.47 Million
Q3 2023

Nov 08, 2023
BUY
$13.28 - $20.3 $199,120 - $304,378
14,994 Added 8.06%
200,989 $3.39 Million
Q2 2023

Aug 09, 2023
BUY
$11.66 - $26.0 $27,156 - $60,554
2,329 Added 1.27%
185,995 $2.55 Million
Q1 2023

May 11, 2023
SELL
$19.47 - $28.49 $16,938 - $24,786
-870 Reduced 0.47%
183,666 $4.17 Million
Q4 2022

Feb 13, 2023
BUY
$18.08 - $30.0 $124,932 - $207,300
6,910 Added 3.89%
184,536 $4.34 Million
Q3 2022

Nov 14, 2022
BUY
$22.51 - $34.32 $148,228 - $225,997
6,585 Added 3.85%
177,626 $4.63 Million
Q2 2022

Aug 15, 2022
BUY
$16.0 - $45.99 $78,848 - $226,638
4,928 Added 2.97%
171,041 $3.76 Million
Q1 2022

May 13, 2022
BUY
$33.17 - $46.98 $139,247 - $197,222
4,198 Added 2.59%
166,113 $7.45 Million
Q4 2021

Feb 11, 2022
BUY
$39.06 - $67.58 $136,397 - $235,989
3,492 Added 2.2%
161,915 $6.94 Million
Q3 2021

Nov 16, 2021
BUY
$60.13 - $77.6 $1.51 Million - $1.95 Million
25,170 Added 18.89%
158,423 $10.5 Million
Q2 2021

Aug 16, 2021
BUY
$50.07 - $76.78 $831,462 - $1.28 Million
16,606 Added 14.24%
133,253 $9.77 Million
Q1 2021

May 17, 2021
BUY
$58.92 - $97.33 $683,177 - $1.13 Million
11,595 Added 11.04%
116,647 $7.99 Million
Q4 2020

Feb 16, 2021
BUY
$43.6 - $73.05 $851,333 - $1.43 Million
19,526 Added 22.83%
105,052 $7.06 Million
Q3 2020

Nov 13, 2020
BUY
$38.47 - $52.03 $2.4 Million - $3.24 Million
62,304 Added 268.3%
85,526 $4.4 Million
Q2 2020

Aug 14, 2020
BUY
$27.28 - $43.01 $16,913 - $26,666
620 Added 2.74%
23,222 $876,000
Q1 2020

May 15, 2020
BUY
$23.08 - $35.53 $283,122 - $435,846
12,267 Added 118.69%
22,602 $674,000
Q4 2019

Feb 07, 2020
BUY
$15.74 - $35.04 $162,672 - $362,138
10,335 New
10,335 $356,000

Others Institutions Holding CSTL

# of Institutions
162
Shares Held
25.3M
Call Options Held
82.2K
Put Options Held
150K
View Full List

About CASTLE BIOSCIENCES INC

CSTL Quotes by TradingView
  • Ticker CSTL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 26,297,000
  • Market Cap $572M
  • Description
  • Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...
More about CSTL
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email